Evaluation of a recombinant Newcastle disease virus expressing human IL12 against human breast cancer
The Newcastle disease virus (NDV) strain AF2240 is an avian avulavirus that has been demonstrated to possess oncolytic activity against cancer cells. However, to illicit a greater anti-cancer immune response, it is believed that the incorporation of immunostimulatory genes such as IL12 into a recomb...
Saved in:
Main Authors: | Mohamed Amin, Zahiah, Che Ani, Muhamad Alhapis, Tan, Sheau Wei, Yeap, Swee Keong, Mohammed Alitheen, Noorjahan Banu, Syed Najmuddin, Syed Umar Faruq, Kalyanasundram, Jeevanathan, Chan, Soon Choy, Veerakumarasivam, Abhimanyu, Chia, Suet Lin, Yusoff, Khatijah |
---|---|
Format: | Article |
Published: |
Nature Publishing Group
2019
|
Online Access: | http://psasir.upm.edu.my/id/eprint/79739/ https://www.nature.com/articles/s41598-019-50222-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncolytic effects of the recombinant newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-foxn1nu nude mice
by: Syed Najmuddin, Syed Umar Faruq, et al.
Published: (2020) -
Engineering recombinant newcastle disease virus with pro-apoptotic gene to enhance oncolysis in selected colorectal cancer cells
by: Kalyanasundram, Jeevanathan
Published: (2020) -
Efficacy of recombinant Newcastle disease virus, RAF-IL12 as a potential therapeutic cancer vaccine in CT26 and HT29 cancer cell line and in mouse model
by: Syed Najmuddin, Syed Umar Faruq
Published: (2019) -
Newcastle disease virus strain AF2240 as an oncolytic virus: a review
by: Kalyanasundram J, Jeevanathan, et al.
Published: (2018) -
Safety and efficacy of recombinant newcastle disease virus expressing human interleukin-12 as a potential vaccine in breast cancer
by: Mohamed Amin, Zahiah
Published: (2019)